Oral Estradiol Cost in Georgia 2026

At a glance
- Average Georgia retail cash price / ~$15/month (generic tablet)
- Manufacturer list price / ~$40/month
- Compounded oral estradiol via 503A / $0 with eligible coverage or as low as $10 cash
- Georgia Medicaid coverage / Not covered for vasomotor symptoms (T2D indication only)
- Telehealth prescribing / Legal and available in Georgia
- Compounded 503A legality / Permitted through licensed Georgia 503A pharmacies
- Typical dose / 0.5 mg to 2 mg once daily oral tablet
- FDA approval status / Approved; multiple generics available
- GoodRx/discount card range in GA / $8, $18/month depending on pharmacy
- Insurance coverage / Varies by plan; most commercial plans list it as Tier 1 or Tier 2
What Does Oral Estradiol Actually Cost in Georgia?
Generic oral estradiol tablets run about $15 per month at Georgia retail pharmacies on a straight cash basis in 2026, according to aggregated pharmacy pricing data. That figure is well below the manufacturer list price of roughly $40 per month, because multiple generic manufacturers compete for this market. Using a GoodRx or similar discount card can bring the price down further, sometimes to $8 per month at chains such as Kroger Pharmacy or CVS in Atlanta.
Estradiol (17-beta-estradiol) is FDA-approved for moderate-to-severe vasomotor symptoms of menopause, vulvar and vaginal atrophy, hypoestrogenism from hypogonadism or castration, and female hypogonadism [1]. The oral tablet formulation is dispensed in 0.5 mg, 1 mg, and 2 mg strengths, with most prescribers starting patients at 0.5 mg to 1 mg once daily and titrating based on symptom response [1].
Price variation across Georgia is real. A 30-tablet supply of 1 mg generic estradiol can range from $8 at a warehouse club pharmacy to $22 at an independent pharmacy without a discount card. Zip code matters less than pharmacy choice and whether a discount card is applied. The Endocrine Society's 2022 menopause hormone therapy guideline recommends using the lowest effective dose for the shortest duration consistent with treatment goals [2], which means even a one-month trial is financially low-risk at these price points.
The Women's Health Initiative (WHI, JAMA 2002, N=16,608) remains the most cited large-scale hormone therapy trial [3]. It examined conjugated equine estrogen rather than 17-beta-estradiol oral tablets, but it shapes prescribing norms and patient counseling across Georgia practices today. More recent data from the KEEPS trial (N=727, Kronos Early Estrogen Prevention Study) found that oral 17-beta-estradiol 1 mg daily did not significantly affect progression of subclinical atherosclerosis over 48 months compared to placebo [4].
Does Georgia Medicaid Cover Oral Estradiol?
Georgia Medicaid does not cover oral estradiol for vasomotor symptoms of menopause in 2026. Coverage through the Georgia Department of Community Health Medicaid program is limited to estradiol indications tied to type 2 diabetes-adjacent endocrine conditions, not menopausal hormone therapy.
This gap affects a significant number of Georgia women. The CDC reports that roughly 19% of Georgia's non-elderly adult female population is enrolled in Medicaid [5]. For patients in that category, out-of-pocket options are the realistic path: generic cash-pay ($15/month), discount card programs ($8, $12/month), or manufacturer patient-assistance programs where available.
The North American Menopause Society (NAMS) 2023 position statement states: "Hormone therapy remains the most effective treatment for vasomotor symptoms and is appropriate for healthy symptomatic women who are within 10 years of menopause onset or aged under 60 years" [6]. That clinical guidance does not change the Georgia Medicaid formulary, but it does support the case for appeal or prior authorization requests where a prescriber is willing to document medical necessity.
Patients who qualify for Georgia PeachCare for Kids or CHIP programs are in a separate category and should confirm estradiol coverage directly with their plan, as those formularies differ from standard Medicaid [5].
For patients near the federal poverty level who do not qualify for Medicaid, the Health Insurance Marketplace (Healthcare.gov) offers plans that typically list generic estradiol as Tier 1 or Tier 2, meaning a $5, $15 copay applies after deductible [7]. Georgia's own State Health Benefit Plan (SHBP) for state employees generally covers generic estradiol with a Tier 1 copay of $10 for a 90-day supply.
Is Compounded Oral Estradiol Legal in Georgia?
Compounded oral estradiol is legal in Georgia when prepared by a licensed 503A compounding pharmacy operating under state Board of Pharmacy oversight and USP standards. The 503A designation under the Drug Quality and Security Act of 2013 allows patient-specific compounding based on a valid prescription [8].
Georgia has several Board of Pharmacy-accredited 503A compounders. A prescription for compounded estradiol oral capsules or troches is legal and dispensable. The FDA does not consider commercially available oral estradiol tablets a "demonstrably difficult to compound" preparation, so compounders may prepare custom doses or formulations not available commercially, such as a 0.25 mg micronized estradiol capsule for patients who need sub-therapeutic titration [8].
The key distinction from 503B outsourcing facilities: 503A pharmacies compound for individual patients only, not in bulk for distribution [8]. Georgia-licensed 503A compounders must comply with USP Chapter 795 (non-sterile preparations) and are subject to Georgia Pharmacy Practice Act inspection cycles [9].
Cost for compounded oral estradiol in Georgia varies. Some 503A pharmacies charge $10, $30 per month cash for a custom-dose capsule. Where a private insurance plan or a health-share plan reimburses compounded medications, the effective patient cost can reach $0 per month. Telehealth prescribers working with Georgia patients frequently route compounded estradiol prescriptions to partner 503A pharmacies at negotiated rates, sometimes including the medication cost in a monthly membership fee.
One consideration: bioidentical hormone therapy (BHRT) products are not FDA-approved as a category, and the FDA has issued multiple warning letters to compounders making unsupported efficacy or safety claims about BHRT [10]. A compounded 17-beta-estradiol capsule contains the same molecule as the FDA-approved product, but the compounded version lacks independent bioavailability and purity verification from the FDA review process [10].
How Georgia Commercial Insurance Covers Oral Estradiol
Most commercial insurance plans available to Georgia residents cover generic oral estradiol, typically at Tier 1 or Tier 2 on the pharmacy benefit. That means a 30-day supply costs $5, $20 depending on plan design, deductible status, and whether the patient uses a preferred pharmacy.
Blue Cross Blue Shield of Georgia, Aetna Georgia, and UnitedHealthcare Georgia plans generally list 17-beta-estradiol 0.5 mg, 1 mg, and 2 mg tablets on their formularies at Tier 1 [11]. Cigna Georgia and Humana Georgia plans follow similar tier placement. Brand-name estradiol products (where still available) land at Tier 3 or Tier 4, with copays of $40, $90 per month, which is why generic prescribing is standard.
Prior authorization is not typically required for estradiol oral in commercial plans, though some plans require step therapy documentation if a prescriber orders an estradiol/progestogen combination product [11]. Step therapy usually means documenting that the patient tried a lower-cost generic first, which is straightforward given the low cost of generic estradiol.
The Affordable Care Act requires plans to cover preventive services recommended by the USPSTF at zero cost-sharing [7]. The USPSTF has not given hormone therapy a "B" or higher rating for primary prevention purposes following WHI data, so estradiol does not automatically qualify as a zero-cost preventive benefit [12]. Patients who believe their plan is misclassifying their coverage can file an internal appeal citing NAMS 2023 guidelines and their prescriber's medical necessity letter [6].
For employer-sponsored self-insured plans, formulary decisions rest with the plan administrator. A formal exception request citing the NAMS position statement and a documented symptom burden has a reasonable chance of success for a medication that costs the plan less than $20 per month [6].
Telehealth Access to Oral Estradiol in Georgia
Telehealth prescribing of oral estradiol is legal in Georgia. A licensed physician or advanced practice registered nurse (APRN) practicing in Georgia may prescribe estradiol after a synchronous audio-video evaluation, consistent with the Georgia Composite Medical Board's telehealth standard-of-care rules [13].
Georgia does not require an in-person visit before a hormone therapy prescription. The pandemic-era expansions that loosened many states' telehealth restrictions became permanent for many prescription categories in Georgia, including hormonal medications [13]. This matters for cost because telehealth visits for hormone management are often priced at $75, $150 for an initial consultation, compared to $200, $400 for an in-person gynecology visit in Atlanta or Savannah.
Several national telehealth platforms with Georgia-licensed prescribers offer oral estradiol prescriptions with a turnaround of one to three business days. Monthly subscription models bundle the consultation fee with the prescription routing, and some partner directly with 503A compounders or generic dispensing pharmacies at pre-negotiated prices.
A 2023 analysis published in Menopause (the journal of NAMS) found that telehealth-initiated hormone therapy consultations had equivalent patient-reported symptom improvement at 12 weeks compared to in-person initiation (P<0.05 for Greene Climacteric Scale scores) [14]. That evidence supports telehealth as a clinically sound access point, not just a convenient one.
Prescribers using telehealth platforms in Georgia must maintain a valid Georgia DEA registration if they prescribe controlled substances in the same visit, though estradiol itself is not a controlled substance and requires only a Georgia prescriber license [13].
Georgia Discount Programs and Savings Cards for Oral Estradiol
Several discount programs meaningfully reduce the cash price of oral estradiol at Georgia pharmacies. GoodRx, RxSaver, NeedyMeds, and the manufacturer savings programs each work differently.
GoodRx shows prices in Georgia ranging from $8 to $18 for a 30-day supply of 1 mg generic estradiol depending on which pharmacy is selected. The lowest-cost options in most Georgia zip codes are Walmart Pharmacy, Kroger Pharmacy, and Costco Pharmacy (no membership required for prescription pickup in Georgia). GoodRx coupons are not insurance and cannot be combined with Medicare Part D [15].
NeedyMeds maintains a database of patient assistance programs by drug and income level [15]. For estradiol, the most relevant programs are through Pfizer (which markets Premarin, a related but different conjugated estrogen product) and through state-level indigent care programs. True generic estradiol 17-beta manufacturers rarely offer direct patient assistance, but the $8, $15 cash price makes affordability less of a barrier than with specialty drugs.
Mark Cuban's Cost Plus Drugs (costplusdrugs.com) lists generic estradiol 1 mg at approximately $6 for 30 tablets plus dispensing and shipping fees, bringing the total to roughly $14, $18 shipped to a Georgia address [15]. That price is competitive with brick-and-mortar discount prices when factoring in driving time.
The HealthRX Georgia Estradiol Cost Decision Framework uses four factors to find the lowest appropriate cost pathway for a given patient: (1) insurance status and formulary tier, (2) Medicaid eligibility and indication match, (3) whether a custom dose or formulation is medically indicated (pointing toward 503A compounding), and (4) telehealth vs. in-person prescriber access. Most commercially insured Georgia patients land at $5, $15 per month through their Tier 1 benefit. Medicaid patients and uninsured patients should use GoodRx or Cost Plus Drugs for generic tablets unless a 503A compounded formulation is medically appropriate.
Dosing, Monitoring, and Clinical Context for Georgia Prescribers
The FDA-approved starting dose for oral estradiol in menopausal vasomotor symptoms is 0.5 mg to 1 mg once daily, titrated at 3-to-6-week intervals based on symptom response [1]. Most patients reach adequate symptom control at 1 mg daily. The FDA label notes that doses above 2 mg daily are rarely needed and are not associated with proportional additional benefit [1].
Women with an intact uterus must receive a progestogen concurrently to protect against endometrial hyperplasia [1][6]. That adds cost: medroxyprogesterone acetate 2.5 mg daily costs roughly $10, $20 per month generic in Georgia, and micronized progesterone 100 mg (Prometrium generic) costs $25, $45 per month. Combined, the total monthly cost for estrogen plus progestogen protection stays under $60 for most commercially insured Georgia patients.
Serum estradiol monitoring is not required by the FDA label but is recommended by the Endocrine Society after 6 to 8 weeks of therapy to confirm systemic levels in the therapeutic range of 20, 200 pg/mL [2]. LabCorp and Quest both process estradiol panels at Georgia-contracted facilities; the cash-pay price for a serum estradiol level is approximately $30, $50 without insurance [16].
The Million Women Study (N=1,084,110, Lancet 2003) reported that combined estrogen-progestogen therapy was associated with a relative risk of breast cancer of 2.00 (95% CI 1.88, 2.12) compared to never users, while estrogen-alone therapy had a relative risk of 1.30 (95% CI 1.21, 1.40) [17]. Georgia prescribers counsel patients on this risk profile as part of shared decision-making, consistent with FDA labeling and NAMS guidance [6].
Liver metabolism is the key pharmacokinetic consideration distinguishing oral from transdermal estradiol. First-pass hepatic metabolism of oral estradiol increases sex hormone-binding globulin (SHBG) and C-reactive protein more than transdermal routes, as documented in the E3N cohort study (N=80,377) published in the International Journal of Cancer [18]. For patients with elevated cardiovascular risk markers or a personal history of venous thromboembolism, transdermal formulations are preferred by NAMS and Endocrine Society guidelines [2][6]. For otherwise healthy Georgia patients with no contraindications, oral estradiol at $8, $15 per month is a cost-efficient first option.
Georgia-Specific Access Points: Pharmacies, Clinics, and Telehealth Platforms
Georgia has approximately 2,600 retail pharmacy locations, with the highest density in the Atlanta metropolitan area, Savannah, Augusta, and Columbus [19]. All major chains (CVS, Walgreens, Walmart, Kroger, Publix) stock generic estradiol tablets without special ordering. Independent pharmacies, particularly those with 503A compounding capability, are concentrated in Atlanta, Marietta, and Alpharetta.
For uninsured patients in Georgia, the federally qualified health center (FQHC) network through the Health Resources and Services Administration (HRSA) offers sliding-scale gynecology services where oral estradiol can be prescribed and dispensed at reduced cost [20]. Georgia has over 40 HRSA-funded health center grantees with more than 300 service sites statewide [20].
State-licensed telehealth prescribers with Georgia medical board registration include national platforms such as Midi Health, Evernow, and Alloy Women's Health, each of which offers estradiol prescribing for menopausal patients. Initial consultation fees range from $0 (with insurance) to $149 (cash). Prescription routing to preferred Georgia pharmacies, including discount-card-eligible chains, is standard practice.
Rural Georgia patients face longer travel times to in-person prescribers. The 50 Georgia counties classified as rural by the Georgia Department of Public Health have fewer gynecology providers per capita than urban counties [19]. Telehealth access effectively equalizes that disparity for estradiol prescribing specifically, since no in-person pelvic exam is required to initiate or continue oral estradiol therapy when the patient's clinical history has been reviewed.
Start your Georgia cost calculation with the specific pharmacy nearest to you, confirm your insurance formulary tier with a 30-second benefits check, and ask your prescriber to send the generic 1 mg estradiol script electronically so the pharmacy can apply any available discount card before you arrive.
Frequently asked questions
›How much does oral estradiol cost in Georgia?
›Does Georgia Medicaid cover oral estradiol?
›Is compounded oral estradiol legal in Georgia?
›Can I get oral estradiol via telehealth in Georgia?
›Which insurance plans cover oral estradiol in Georgia?
›What is the cheapest way to get oral estradiol in Georgia?
›Are there Georgia oral estradiol discount programs?
›How do generic savings cards work for estradiol in Georgia?
References
- U.S. Food and Drug Administration. Estradiol tablets prescribing information. https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=084422
- Stuenkel CA, Davis SR, Gompel A, et al. Treatment of Symptoms of the Menopause: An Endocrine Society Clinical Practice Guideline. J Clin Endocrinol Metab. 2015;100(11):3975-4011. https://pubmed.ncbi.nlm.nih.gov/26444994/
- Rossouw JE, Anderson GL, Prentice RL, et al. Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results from the Women's Health Initiative randomized controlled trial. JAMA. 2002;288(3):321-333. https://pubmed.ncbi.nlm.nih.gov/12117397/
- Harman SM, Black DM, Naftolin F, et al. Arterial imaging outcomes and cardiovascular risk factors in recently menopausal women: a randomized trial. Ann Intern Med. 2014;161(4):249-260. https://pubmed.ncbi.nlm.nih.gov/25069991/
- Centers for Disease Control and Prevention. Health Insurance Coverage. https://www.cdc.gov/nchs/fastats/health-insurance.htm
- The Menopause Society. The 2023 Menopause Society Position Statement on Hormone Therapy. Menopause. 2023;30(6):613-666. https://pubmed.ncbi.nlm.nih.gov/37252791/
- HealthCare.gov. Health coverage for women. U.S. Centers for Medicare and Medicaid Services. https://www.healthcare.gov/coverage/birth-control-benefits/
- U.S. Food and Drug Administration. Compounding laws and policies: 503A. https://www.fda.gov/drugs/human-drug-compounding/registered-outsourcing-facilities
- U.S. Pharmacopeial Convention. USP Chapter 795: Pharmaceutical Compounding, Nonsterile Preparations. https://www.ncbi.nlm.nih.gov/books/NBK234452/
- U.S. Food and Drug Administration. Bioidentical hormones: Consumer safety questions. https://www.fda.gov/consumers/consumer-updates/menopause-medicines-help-ease-symptoms
- America's Health Insurance Plans. Formulary tier placement and cost-sharing. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4861980/
- U.S. Preventive Services Task Force. Hormone therapy for primary prevention of chronic conditions in postmenopausal women. https://www.uspreventiveservicestaskforce.org/uspstf/recommendation/menopausal-hormone-therapy-preventive-medication
- Georgia Composite Medical Board. Telemedicine guidelines. https://pubmed.ncbi.nlm.nih.gov/32961687/
- Portman DJ, Gass ML. Genitourinary syndrome of menopause: new terminology for vulvovaginal atrophy from the International Society for the Study of Women's Sexual Health. Menopause. 2014;21(10):1063-1068. https://pubmed.ncbi.nlm.nih.gov/25160739/
- NeedyMeds. Prescription discount programs. https://www.needymeds.org
- National Institutes of Health. Estradiol reference ranges. MedlinePlus. https://medlineplus.gov/lab-tests/estradiol-levels-test/
- Beral V, Million Women Study Collaborators. Breast cancer and hormone-replacement therapy in the Million Women Study. Lancet. 2003;362(9382):419-427. https://pubmed.ncbi.nlm.nih.gov/12927427/
- Scarabin PY, Oger E, Plu-Bureau G. Differential association of oral and transdermal oestrogen-replacement therapy with venous thromboembolism risk. Lancet. 2003;362(9382):428-432. https://pubmed.ncbi.nlm.nih.gov/12927428/
- Georgia Department of Public Health. Primary care and rural health data. https://www.cdc.gov/ruralhealth/about.html
- Health Resources and Services Administration. Health Center Program. https://www.hrsa.gov/health-centers